Registry-based Study using HAM-net

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1050220081

Enrollment

628

Registered

2022-08-26

Start date

2022-09-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human T-cell Leukemia Virus Type 1 (HTLV-1)-Associated Myelopathy (HAM)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Patients with HAM who are registered with HAM-net

Exclusion criteria

Exclusion criteria: - Patients who refuse to participate in this study - Patients who are judged by the principal investigator of St. Marianna University School of Medicine to be unsuitable for this study

Design outcomes

Primary

Measure	Time frame
- Natural Course of 10 m Walk Time(10mWT) in a Patient with HAM	—

Contacts

Public ContactInformation Desk Clinical Research

Tanabe Pharma Corporation

cti-inq-ml.JP@ml.tanabe-pharma.com+81-120-753-280

Outcome results